1. Home
  2. LNTH vs BFAM Comparison

LNTH vs BFAM Comparison

Compare LNTH & BFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • BFAM
  • Stock Information
  • Founded
  • LNTH 1956
  • BFAM 1986
  • Country
  • LNTH United States
  • BFAM United States
  • Employees
  • LNTH N/A
  • BFAM N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • BFAM Other Consumer Services
  • Sector
  • LNTH Health Care
  • BFAM Consumer Discretionary
  • Exchange
  • LNTH Nasdaq
  • BFAM Nasdaq
  • Market Cap
  • LNTH 7.5B
  • BFAM 7.1B
  • IPO Year
  • LNTH 2015
  • BFAM 1997
  • Fundamental
  • Price
  • LNTH $75.56
  • BFAM $129.36
  • Analyst Decision
  • LNTH Strong Buy
  • BFAM Buy
  • Analyst Count
  • LNTH 5
  • BFAM 8
  • Target Price
  • LNTH $133.80
  • BFAM $139.13
  • AVG Volume (30 Days)
  • LNTH 1.5M
  • BFAM 560.0K
  • Earning Date
  • LNTH 05-07-2025
  • BFAM 05-05-2025
  • Dividend Yield
  • LNTH N/A
  • BFAM N/A
  • EPS Growth
  • LNTH N/A
  • BFAM 93.82
  • EPS
  • LNTH 3.53
  • BFAM 2.77
  • Revenue
  • LNTH $1,536,699,000.00
  • BFAM $2,728,831,000.00
  • Revenue This Year
  • LNTH $4.63
  • BFAM $9.64
  • Revenue Next Year
  • LNTH $9.35
  • BFAM $7.16
  • P/E Ratio
  • LNTH $21.40
  • BFAM $46.66
  • Revenue Growth
  • LNTH 12.53
  • BFAM 9.71
  • 52 Week Low
  • LNTH $73.11
  • BFAM $100.59
  • 52 Week High
  • LNTH $126.89
  • BFAM $141.90
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 32.65
  • BFAM 57.47
  • Support Level
  • LNTH $73.75
  • BFAM $127.28
  • Resistance Level
  • LNTH $76.34
  • BFAM $132.99
  • Average True Range (ATR)
  • LNTH 2.50
  • BFAM 3.30
  • MACD
  • LNTH -0.09
  • BFAM 0.52
  • Stochastic Oscillator
  • LNTH 23.36
  • BFAM 64.47

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; full-service center-based child care, backup care, and educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

Share on Social Networks: